Article 6CV9R A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It

A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It

by
Emily Mullin
from Feed: All Latest on (#6CV9R)
Story ImageFractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections.
External Content
Source RSS or Atom Feed
Feed Location http://feeds.wired.com/wired/index
Feed Title Feed: All Latest
Feed Link https://www.wired.com/
Feed Copyright © Condé Nast 2024
Reply 0 comments